Bosnia's net electricity output up 17% y/y in Sept
Romania's DN Agrar Group 9-mo net profit surges 111% y/y
Croatia's industrial sales up 1.2% y/y in Sept
Croatia's GDP grows by 2.8% y/y in Q3 - first estimate
N. Macedonia's industrial producer prices fall 3.9% y/y in Oct
Nov 01, 2017 16:05 EEST
SARAJEVO (Bosnia and Herzegovina), November 1 (SeeNews) – Bosnian pharmaceuticals producer Bosnalijek [SAJ:BSNLR] said on Wednesday it turned to a net profit of 5.5 million marka ($3.3 million/2.8 million euro) in the first nine months of 2107, from a 3.0 million marka loss a year earlier.
Operating income grew 35.8% to 92.8 million marka in the nine months through September, while operating costs climbed 21.3% to 85.5 million marka, Bosnalijek said in a filing with the Sarajevo Stock Exchange.
In October last year, the government of Bosnia's Federation entity sold its 19.3% stake in Bosnalijek for 23.4 million marka to Malta-based financial services provider KBC Euro Credit Capital.
The Federation is one of the two autonomous entities that make up Bosnia and Herzegovina. The other one is the Serb Republic.
(1 euro=1.95583 Bosnian marka)
You have run out of free articles this month.
Sign up in for
and get ten (10) free articles per month or sign up for
and get unlimited access.
Browse our free newsletter options